Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations
Top Cited Papers
- 1 May 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 149 (2), 177-193
- https://doi.org/10.1016/j.pain.2010.02.018
Abstract
There has been an increase in the number of chronic pain clinical trials in which the treatments being evaluated did not differ significantly from placebo in the primary efficacy analyses despite previous research suggesting that efficacy could be expected. These findings could reflect a true lack of efficacy or methodological and other aspects of these trials that compromise the demonstration of efficacy. There is substantial variability among chronic pain clinical trials with respect to important research design considerations, and identifying and addressing any methodological weaknesses would enhance the likelihood of demonstrating the analgesic effects of new interventions. An IMMPACT consensus meeting was therefore convened to identify the critical research design considerations for confirmatory chronic pain trials and to make recommendations for their conduct. We present recommendations for the major components of confirmatory chronic pain clinical trials, including participant selection, trial phases and duration, treatment groups and dosing regimens, and types of trials. Increased attention to and research on the methodological aspects of confirmatory chronic pain clinical trials has the potential to enhance their assay sensitivity and ultimately provide more meaningful evaluations of treatments for chronic pain.Keywords
This publication has 127 references indexed in Scilit:
- A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptomsPain, 2009
- Development and psychometric analysis of the PROMIS pain behavior item bankPain, 2009
- Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal PainPublished by American Medical Association (AMA) ,2009
- Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic reviewBritish Journal of Clinical Pharmacology, 2008
- The Patient-Reported Outcomes Measurement Information System (PROMIS)Medical Care, 2007
- Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging studyActa Neurologica Scandinavica, 2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Quantitative sensory testing: a comprehensive protocol for clinical trialsEuropean journal of pain, 2006
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis & Rheumatism, 1991